Porphyrias Treatments Market - Global Outlook and Forecast 2022-2028

March 2022 | 62 pages | ID: P0969DB50A4FEN
Market Monitor Global

Abstracts

Porphyria is a group of diseases in which substances called porphyrins build up, negatively affecting the skin or nervous system.

This report contains market size and forecasts of Porphyrias Treatments in Global, including the following market information:

Global Porphyrias Treatments Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Porphyrias Treatments market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Porphyrin Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Porphyrias Treatments include Lundbeck, Recordati Rare Diseases, Teva Pharmaceutical and Apotex, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Porphyrias Treatments companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Porphyrias Treatments Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Porphyrias Treatments Market Segment Percentages, by Type, 2021 (%)

• Porphyrin
• Dextrose
• Anticonvulsants
• Opioids
• Others

Global Porphyrias Treatments Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Porphyrias Treatments Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Porphyrias Treatments Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Porphyrias Treatments Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Porphyrias Treatments revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Porphyrias Treatments revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Lundbeck
• Recordati Rare Diseases
• Teva Pharmaceutical
• Apotex

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Porphyrias Treatments Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Porphyrias Treatments Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL PORPHYRIAS TREATMENTS OVERALL MARKET SIZE

2.1 Global Porphyrias Treatments Market Size: 2021 VS 2028
2.2 Global Porphyrias Treatments Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Porphyrias Treatments Players in Global Market
3.2 Top Global Porphyrias Treatments Companies Ranked by Revenue
3.3 Global Porphyrias Treatments Revenue by Companies
3.4 Top 3 and Top 5 Porphyrias Treatments Companies in Global Market, by Revenue in 2021
3.5 Global Companies Porphyrias Treatments Product Type
3.6 Tier 1, Tier 2 and Tier 3 Porphyrias Treatments Players in Global Market
  3.6.1 List of Global Tier 1 Porphyrias Treatments Companies
  3.6.2 List of Global Tier 2 and Tier 3 Porphyrias Treatments Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Porphyrias Treatments Market Size Markets, 2021 & 2028
  4.1.2 Porphyrin
  4.1.3 Dextrose
  4.1.4 Anticonvulsants
  4.1.5 Opioids
  4.1.6 Others
4.2 By Type - Global Porphyrias Treatments Revenue & Forecasts
  4.2.1 By Type - Global Porphyrias Treatments Revenue, 2017-2022
  4.2.2 By Type - Global Porphyrias Treatments Revenue, 2023-2028
  4.2.3 By Type - Global Porphyrias Treatments Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Porphyrias Treatments Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacies
  5.1.3 Retail Pharmacies
  5.1.4 Online Pharmacies
5.2 By Application - Global Porphyrias Treatments Revenue & Forecasts
  5.2.1 By Application - Global Porphyrias Treatments Revenue, 2017-2022
  5.2.2 By Application - Global Porphyrias Treatments Revenue, 2023-2028
  5.2.3 By Application - Global Porphyrias Treatments Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Porphyrias Treatments Market Size, 2021 & 2028
6.2 By Region - Global Porphyrias Treatments Revenue & Forecasts
  6.2.1 By Region - Global Porphyrias Treatments Revenue, 2017-2022
  6.2.2 By Region - Global Porphyrias Treatments Revenue, 2023-2028
  6.2.3 By Region - Global Porphyrias Treatments Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Porphyrias Treatments Revenue, 2017-2028
  6.3.2 US Porphyrias Treatments Market Size, 2017-2028
  6.3.3 Canada Porphyrias Treatments Market Size, 2017-2028
  6.3.4 Mexico Porphyrias Treatments Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Porphyrias Treatments Revenue, 2017-2028
  6.4.2 Germany Porphyrias Treatments Market Size, 2017-2028
  6.4.3 France Porphyrias Treatments Market Size, 2017-2028
  6.4.4 U.K. Porphyrias Treatments Market Size, 2017-2028
  6.4.5 Italy Porphyrias Treatments Market Size, 2017-2028
  6.4.6 Russia Porphyrias Treatments Market Size, 2017-2028
  6.4.7 Nordic Countries Porphyrias Treatments Market Size, 2017-2028
  6.4.8 Benelux Porphyrias Treatments Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Porphyrias Treatments Revenue, 2017-2028
  6.5.2 China Porphyrias Treatments Market Size, 2017-2028
  6.5.3 Japan Porphyrias Treatments Market Size, 2017-2028
  6.5.4 South Korea Porphyrias Treatments Market Size, 2017-2028
  6.5.5 Southeast Asia Porphyrias Treatments Market Size, 2017-2028
  6.5.6 India Porphyrias Treatments Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Porphyrias Treatments Revenue, 2017-2028
  6.6.2 Brazil Porphyrias Treatments Market Size, 2017-2028
  6.6.3 Argentina Porphyrias Treatments Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Porphyrias Treatments Revenue, 2017-2028
  6.7.2 Turkey Porphyrias Treatments Market Size, 2017-2028
  6.7.3 Israel Porphyrias Treatments Market Size, 2017-2028
  6.7.4 Saudi Arabia Porphyrias Treatments Market Size, 2017-2028
  6.7.5 UAE Porphyrias Treatments Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Lundbeck
  7.1.1 Lundbeck Corporate Summary
  7.1.2 Lundbeck Business Overview
  7.1.3 Lundbeck Porphyrias Treatments Major Product Offerings
  7.1.4 Lundbeck Porphyrias Treatments Revenue in Global Market (2017-2022)
  7.1.5 Lundbeck Key News
7.2 Recordati Rare Diseases
  7.2.1 Recordati Rare Diseases Corporate Summary
  7.2.2 Recordati Rare Diseases Business Overview
  7.2.3 Recordati Rare Diseases Porphyrias Treatments Major Product Offerings
  7.2.4 Recordati Rare Diseases Porphyrias Treatments Revenue in Global Market (2017-2022)
  7.2.5 Recordati Rare Diseases Key News
7.3 Teva Pharmaceutical
  7.3.1 Teva Pharmaceutical Corporate Summary
  7.3.2 Teva Pharmaceutical Business Overview
  7.3.3 Teva Pharmaceutical Porphyrias Treatments Major Product Offerings
  7.3.4 Teva Pharmaceutical Porphyrias Treatments Revenue in Global Market (2017-2022)
  7.3.5 Teva Pharmaceutical Key News
7.4 Apotex
  7.4.1 Apotex Corporate Summary
  7.4.2 Apotex Business Overview
  7.4.3 Apotex Porphyrias Treatments Major Product Offerings
  7.4.4 Apotex Porphyrias Treatments Revenue in Global Market (2017-2022)
  7.4.5 Apotex Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Porphyrias Treatments Market Opportunities & Trends in Global Market
Table 2. Porphyrias Treatments Market Drivers in Global Market
Table 3. Porphyrias Treatments Market Restraints in Global Market
Table 4. Key Players of Porphyrias Treatments in Global Market
Table 5. Top Porphyrias Treatments Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Porphyrias Treatments Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Porphyrias Treatments Revenue Share by Companies, 2017-2022
Table 8. Global Companies Porphyrias Treatments Product Type
Table 9. List of Global Tier 1 Porphyrias Treatments Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Porphyrias Treatments Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Porphyrias Treatments Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Porphyrias Treatments Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Porphyrias Treatments Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Porphyrias Treatments Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Porphyrias Treatments Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Porphyrias Treatments Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Porphyrias Treatments Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Porphyrias Treatments Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Porphyrias Treatments Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Porphyrias Treatments Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Porphyrias Treatments Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Porphyrias Treatments Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Porphyrias Treatments Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Porphyrias Treatments Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Porphyrias Treatments Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Porphyrias Treatments Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Porphyrias Treatments Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Porphyrias Treatments Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Porphyrias Treatments Revenue, (US$, Mn), 2023-2028
Table 30. Lundbeck Corporate Summary
Table 31. Lundbeck Porphyrias Treatments Product Offerings
Table 32. Lundbeck Porphyrias Treatments Revenue (US$, Mn), (2017-2022)
Table 33. Recordati Rare Diseases Corporate Summary
Table 34. Recordati Rare Diseases Porphyrias Treatments Product Offerings
Table 35. Recordati Rare Diseases Porphyrias Treatments Revenue (US$, Mn), (2017-2022)
Table 36. Teva Pharmaceutical Corporate Summary
Table 37. Teva Pharmaceutical Porphyrias Treatments Product Offerings
Table 38. Teva Pharmaceutical Porphyrias Treatments Revenue (US$, Mn), (2017-2022)
Table 39. Apotex Corporate Summary
Table 40. Apotex Porphyrias Treatments Product Offerings
Table 41. Apotex Porphyrias Treatments Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Porphyrias Treatments Segment by Type in 2021
Figure 2. Porphyrias Treatments Segment by Application in 2021
Figure 3. Global Porphyrias Treatments Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Porphyrias Treatments Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Porphyrias Treatments Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Porphyrias Treatments Revenue in 2021
Figure 8. By Type - Global Porphyrias Treatments Revenue Market Share, 2017-2028
Figure 9. By Application - Global Porphyrias Treatments Revenue Market Share, 2017-2028
Figure 10. By Region - Global Porphyrias Treatments Revenue Market Share, 2017-2028
Figure 11. By Country - North America Porphyrias Treatments Revenue Market Share, 2017-2028
Figure 12. US Porphyrias Treatments Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Porphyrias Treatments Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Porphyrias Treatments Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Porphyrias Treatments Revenue Market Share, 2017-2028
Figure 16. Germany Porphyrias Treatments Revenue, (US$, Mn), 2017-2028
Figure 17. France Porphyrias Treatments Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Porphyrias Treatments Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Porphyrias Treatments Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Porphyrias Treatments Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Porphyrias Treatments Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Porphyrias Treatments Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Porphyrias Treatments Revenue Market Share, 2017-2028
Figure 24. China Porphyrias Treatments Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Porphyrias Treatments Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Porphyrias Treatments Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Porphyrias Treatments Revenue, (US$, Mn), 2017-2028
Figure 28. India Porphyrias Treatments Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Porphyrias Treatments Revenue Market Share, 2017-2028
Figure 30. Brazil Porphyrias Treatments Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Porphyrias Treatments Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Porphyrias Treatments Revenue Market Share, 2017-2028
Figure 33. Turkey Porphyrias Treatments Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Porphyrias Treatments Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Porphyrias Treatments Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Porphyrias Treatments Revenue, (US$, Mn), 2017-2028
Figure 37. Lundbeck Porphyrias Treatments Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Recordati Rare Diseases Porphyrias Treatments Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Teva Pharmaceutical Porphyrias Treatments Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Apotex Porphyrias Treatments Revenue Year Over Year Growth (US$, Mn) & (2017-2022)